Member Info for ratcliffewriter

Agreed, but CH was right to point out they have many 'shots at goal'. Not a case of all eggs in one basket, so imo very appealing indeed.

Agreed Knowlesi, but before you disappear can you actually find ANY post (other than your own) where anyone has said 'buy buy buy'? You 'quote' it so often, but it doesn't seem to exist other than in your own occasionally rather fertile imagination.

And they're off!!

A play on words - From the Urban Dictionary
- never mind the quality..feel the width. Phrase used to persuade you that quantitiy is more important than quality. Originated from unscrupulous London backstreet tailors fobbing you off with cheap material instead of the good stuff for your suit.
"Hmm. This suit smells bad and is sturdy enough to both restrain a rutting wart hog and give me heat-stroke if the mercury climbs above 60 degrees, my good man".
"Never mind the quality, feel the width my son! They don't make cloth like this anymore!"

Now, back to business!

To reverse a saying, 'never mind the width, feel the quality.'

Post rec crumbs. I've always subscribed to the idea of 'when, not if.'
Exactly 'when' is always open to conjecture, but its arrival seems to me to be getting significantly closer.

Given the developments in the company and the events expected by the majority in the future (near and far) I imagine these options will remain unexercised for some while. After all they could have been exercised at any time over the past many years and yielded a decent profit, but have not been.

Not exactly balanced is it Bunsie? Wins 'Liar and Fantasist of the decade' anyway.

I don't know about anyone else, but I invested here on the science, and didn't put in more than I can afford to lose. Those who have on occasion tried to say how many shares I own, and if I have bought or sold, are basically liars and deception merchants. Only my stockbroker and financial advisor know the facts.
During all the time I have been invested here, I have continually reappraised the science and am happier than ever that there is a great future coming here. However, as I have said on a number of occasions, a decision to buy, sell or hold is down to the individual on what they know, understand or discover.
Unfortunately there are some very dishonest people floating about who have a very dark and organised agenda from what I have seen, and I believe GF123 has a fair idea about them too. Meanwhile, things are (imo) looking extremely promising for Scancell. Toodle pip!

Who knows? But if/when a deal is signed for Avidimab it will give a very good idea of how the future will pan out.

Correction to that, I think it was 100-200 million milestones in fact, but again it was said as an illustration of a general deal, very much not said in relation to a possible scancell MaB deal. He was careful to distance generals from specifics which is interesting and intriguing.

That's the thing though - CH said a standard preclinical MaB deal is low millions upfront with milestones of 100-200k, but I felt he was very specific in distancing those figures from anything relating to a scancell-specific MaB deal. He actually gave nothing away on specifc relevant figures because, presumably, he is actually talking deal figures right now, if deals are to be announced in a couple of months. So any deal could be in the area he alluded to, or could be considerably greater. Can't see it being less than 1 million personally, but that's just an opinion.

It is, but that's the one that was posted the other day anyway.

Https://register.epo.org/application?number=EP17194251&lng=en&tab=event

Lovely video - once the covid things subsides (come on Lindy!) I will be doing another Scottish run. Just checked and 1952 was the father in law's best year - he was mechanic to Ken Wharton who won that year. He and Ken were together for a good few years with Coopers and ERAs. O/T I know, but while it's quiet... Anyway, wonder if we will have any Sunday paper coverage for the advancements?

My late father in law used to compete in hill climbs up RABT in the post war period.

Avidimab certainly looks like the closest at the moment of the 'many shots on goal.'
I was also very impressed with the fluency and depth of knowledge he showed - his previous presentations and interviews have been fine, but this was a big step up, almost as impressive as Lindy in terms of imparting structured detail, as if he has been talking a great deal at a high level. Which it appears he has.

There may only have been a hundred and something viewers last night, but the YouTube recording is showing well over 1300 views so far. Encouraging.

A tick up anyway - 8/8.50.

And no concerns at all regarding funding, even without a deal on avidimab in the next couple of months.